Rep. Julie Johnson Sells Off Shares of Agilent Technologies, Inc. (NYSE:A)

Representative Julie Johnson (D-Texas) recently sold shares of Agilent Technologies, Inc. (NYSE:A). In a filing disclosed on April 14th, the Representative disclosed that they had sold between $1,001 and $15,000 in Agilent Technologies stock on March 3rd. The trade occurred in the Representative’s “MERRILL LYNCH LONG TERM GROWTH” account.

Representative Julie Johnson also recently made the following trade(s):

• Purchased $1,001 – $15,000 in shares of Capital One Financial (NYSE:COF) on 3/21/2025.
• Sold $1,001 – $15,000 in shares of Accenture (NYSE:ACN) on 3/19/2025.
• Purchased $1,001 – $15,000 in shares of The Cigna Group (NYSE:CI) on 3/19/2025.
• Sold $1,001 – $15,000 in shares of Accenture (NYSE:ACN) on 3/14/2025.
• Sold $1,001 – $15,000 in shares of Accenture (NYSE:ACN) on 3/12/2025.
• Purchased $1,001 – $15,000 in shares of 3M (NYSE:MMM) on 3/12/2025.
• Sold $1,001 – $15,000 in shares of Webster Financial (NYSE:WBS) on 3/11/2025.
• Sold $1,001 – $15,000 in shares of Sonos (NASDAQ:SONO) on 3/11/2025.
• Sold $1,001 – $15,000 in shares of Taiwan Semiconductor Manufacturing (NYSE:TSM) on 3/11/2025.
• Sold $1,001 – $15,000 in shares of Teradyne (NASDAQ:TER) on 3/3/2025.

Agilent Technologies Price Performance

Shares of Agilent Technologies stock opened at $102.80 on Thursday. The business has a 50 day moving average of $121.16 and a 200 day moving average of $133.12. Agilent Technologies, Inc. has a 52 week low of $96.43 and a 52 week high of $155.35. The company has a quick ratio of 1.66, a current ratio of 2.20 and a debt-to-equity ratio of 0.56. The company has a market cap of $29.31 billion, a PE ratio of 23.63, a P/E/G ratio of 2.90 and a beta of 1.19.

Agilent Technologies (NYSE:A) last released its earnings results on Wednesday, February 26th. The medical research company reported $1.31 earnings per share for the quarter, topping analysts’ consensus estimates of $1.27 by $0.04. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. The firm had revenue of $1.68 billion for the quarter, compared to the consensus estimate of $1.67 billion. As a group, equities research analysts forecast that Agilent Technologies, Inc. will post 5.55 earnings per share for the current year.

Agilent Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be paid a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, April 1st. This represents a $0.99 annualized dividend and a dividend yield of 0.96%. Agilent Technologies’s payout ratio is presently 22.76%.

Institutional Trading of Agilent Technologies

Several large investors have recently modified their holdings of the company. Ritholtz Wealth Management boosted its stake in shares of Agilent Technologies by 25.3% during the 1st quarter. Ritholtz Wealth Management now owns 2,953 shares of the medical research company’s stock worth $345,000 after acquiring an additional 596 shares during the last quarter. Dohj LLC grew its holdings in Agilent Technologies by 4.3% during the first quarter. Dohj LLC now owns 5,843 shares of the medical research company’s stock valued at $683,000 after purchasing an additional 239 shares during the period. Opal Wealth Advisors LLC purchased a new stake in Agilent Technologies in the first quarter worth about $31,000. Wealth Enhancement Advisory Services LLC raised its stake in shares of Agilent Technologies by 86.3% in the first quarter. Wealth Enhancement Advisory Services LLC now owns 51,363 shares of the medical research company’s stock worth $6,009,000 after buying an additional 23,800 shares during the period. Finally, New England Research & Management Inc. purchased a new position in shares of Agilent Technologies during the 1st quarter valued at about $1,664,000.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on A shares. Citigroup boosted their price target on Agilent Technologies to $165.00 and gave the stock a “buy” rating in a research report on Thursday, December 19th. TD Cowen increased their target price on Agilent Technologies to $135.00 and gave the stock a “buy” rating in a research note on Thursday, April 10th. Robert W. Baird reduced their price target on Agilent Technologies from $161.00 to $159.00 and set an “outperform” rating for the company in a report on Thursday, February 27th. StockNews.com upgraded shares of Agilent Technologies from a “hold” rating to a “buy” rating in a research note on Tuesday, December 24th. Finally, Barclays decreased their target price on shares of Agilent Technologies from $138.00 to $115.00 and set an “equal weight” rating for the company in a report on Thursday, April 10th. Seven equities research analysts have rated the stock with a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $146.25.

Insider Activity at Agilent Technologies

In other news, CEO Padraig Mcdonnell sold 1,911 shares of the business’s stock in a transaction dated Tuesday, January 21st. The stock was sold at an average price of $150.00, for a total value of $286,650.00. Following the transaction, the chief executive officer now directly owns 39,652 shares in the company, valued at $5,947,800. The trade was a 4.60 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of the stock in a transaction that occurred on Monday, March 17th. The shares were sold at an average price of $121.98, for a total transaction of $232,737.84. Following the sale, the vice president now directly owns 21,786 shares of the company’s stock, valued at approximately $2,657,456.28. This trade represents a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 5,638 shares of company stock worth $731,229.

About Representative Johnson

Julie Johnson (Democratic Party) is a member of the U.S. House, representing Texas’ 32nd Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.

Johnson (Democratic Party) ran for election to the U.S. House to represent Texas’ 32nd Congressional District. She won in the general election on November 5, 2024.

Julie Johnson earned a B.A. in history and government from the University of Texas at Austin in 1987 and a J.D. from the University of Houston Law Center in 1991. Johnson’s career experience includes working as an attorney.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.